Page 20 - Sun Pharma

Sun Pharma Q3 results: Net profit rises 11% to Rs 2,059 cr

Total revenue from operations rose to Rs 9,863 cr in the third quarter as compared to Rs 8,836.7 cr in the same period of previous fiscal

Sun Pharma-arm Taro logs better-than-expected Q3 Ebitda margin; stock up 4%

In Q3FY22, Taro's EBITDA margins improved 108 bps year-on-year (YoY) to 31.3 per cent mainly due to better gross margins.

Sun Pharma launches dry eye treatment product in Canada

This launch is an important milestone for the drugmaker as it expands its ophthalmics portfolio into Canada, the firm said

Bharti Airtel, L&T, M&M among top trading bets ahead of Budget 2022

Major stocks have broken out on upside, any trigger in Budget 2022 could see sharp up move

Sun Pharma gains 4% on earnings optimism, stock scales a 5-year high

The better traction in the specialty segment and improvement in domestic business to drive the margin expansion in Q3.

Sun Pharma expected to shine on domestic prospects, US sales ramp up

Anti-covid drug approval, new facility are the near term triggers for the pharma firm's stock

Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high

Sun Pharma, Cipla, Natco, Dr Reddy's, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI

Stocks to Watch: Textiles, Amara Raja, Airtel, TCS, ITC, Ajanta Pharma

Textiles shares shall be in limelight as the government has released the operational guidelines for the production-linked incentive (PLI) scheme

Sun Pharma to set up new manufacturing plant in Andhra Pradesh

Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world

Top headlines: Sebi's new measures for IPO market; Covid curbs in Delhi

Business Standard brings you the top headlines on Tuesday

Sun Pharma Advanced Research Co signs licensing pact with Biomodifying

Biomodifying will also receive a percentage of payments received for sublicenses of the licensed IP

Sun Pharma to launch Merck's Covid pill under brand name 'Molxvir' in India

Sun Pharmaceutical Industries said it is gearing up to introduce Merck Sharp Dohme and Ridgeback's molnupiravir under the brand name Molxvir in India

Leading drug makers Sun Pharma, Lupin recall products in US market

According to USFDA, the Mumbai-based drug maker is recalling the affected lot due to "failed moisture limits."

Stocks to Watch: SBI, Airtel, SpiceJet, Trent, Mtar, Pfizer, HPCL, Bata

SBI and other banking shares, along with stocks of companies to report earnings today will be in focus

Sun Pharma Q2 net up 13% at Rs 2,047 cr, firm launches 28 products in qtr

Taro-adjusted net profit down by 45% YoY

Sun Pharma second quarter net profit rises 13% to Rs 2,047 crore

The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal

Stocks to Watch: Airtel, Dabur, Sun Pharma, HDFC, IRCTC, Steel, Gold stocks

Gold and steel related stocks are likely to hog the limelight in trades on Tuesday. The former on the account of Dhanteras, while the latter owing to hike in steel prices

Q2 preview: Non-Covid revenues to hint at normalisation for healthcare cos

Companies may, however, report sequential drop in numbers as Q1FY22 coincided with outbreak of second Covid wave, say brokerages

Sun Pharma hits over 5-yr high on hopes of robust revenue growth in Q2

Motilal Oswal Securities remains positive on Sun Pharma due to investments in the global Specialty portfolio improving overall profitability

Sun Pharma gains 4% in 2 days after launching cough syrup Chericof 12

Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug